BFRI
Biofrontera Inc.
Nasdaq Pharmaceutical Preparations
Emerging growth company

Key Financials

Net Income
$-10536000
↑ 40.7%
Operating Income
$-11348000
↑ 34.1%
Shareholders' Equity
$10.5M
↑ 136.4%
Total Assets
$28.6M
↑ 29.2%
Revenue
$41.7M
↑ 11.7%
Total Liabilities
$18.1M
↑ 2.4%
EPS (Diluted)
$-1.04
↑ 67.7%
Cash & Equivalents
$6.4M
↑ 8.2%

Recent SEC Filings

Form Type Filed Date Link
8-K 6/17/2026 View on SEC
10-Q 5/14/2026 View on SEC
8-K 5/14/2026 View on SEC
DEF 14A 4/30/2026 View on SEC
10-K 3/19/2026 View on SEC
8-K 3/19/2026 View on SEC
8-K 3/9/2026 View on SEC
4 3/6/2026 View on SEC
4 3/6/2026 View on SEC
4 3/6/2026 View on SEC

Company Information

Field Value
Ticker BFRI
Company Name Biofrontera Inc.
CIK 1858685
Sector Pharmaceutical Preparations
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 781-245-1325